References

zabmedvestnik

Забайкальский медицинский вестник

Transbaikalian Medical Bulletin

1998-6173

Читинская государственная медицинская академия

10.52485/19986173_2021_1_103

zabmedvestnik-58

Research Article

НАУЧНЫЕ ОБЗОРЫ

SCIENTIFIC REVIEWS

Возможности и принципы эндоскопической диагностики на разных этапах каскада Корреа

Opportunities and principles of endoscopic diagnosis of different stages of correa’s cascade

Скажутина

Т. В.

Skazhutina

T. V.

143400, г. Красногорск, Ильинское шоссе, военный городок «Павшино» 2, корпус В

2, housing BIlyinskoye highway, «Pavshino», Krasnogorsk, 143400.

Цепелев

В. Л.

Tsepelev

V. L.

672000, г. Чита, ул. Горького 39а

39A Gorky str., Chita, 672000

Государственное бюджетное учреждение здравоохранения «Красногорская городская больница № 2»РоссияKrasnogorsk City Hospital №2Russian Federation

Федеральное государственное бюджетное образовательное учреждение высшего образования «Читинская государственная медицинская академия» Министерства здравоохранения Российской ФедерацииРоссияChita State Medical AcademyRussian Federation

2021

30072024

01103116

2024

Скажутина Т.В., Цепелев В.Л.

Skazhutina T.V., Tsepelev V.L.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.zabmedvestnik.ru/jour/article/view/58

В обзоре обобщены данные литературы о роли эндоскопии в диагностике каскада Корреа, который представляет собой последовательное развитие аденокарциномы через этапы прогрессирования предраковых состояний от хронического неатрофического гастрита к хроническому атрофическому гастриту с последующим формированием кишечной метаплазии, приводящей к интраэпителиальной неоплазии. Особое внимание уделено критериям ранней диагностики аденокарциномы желудка. Представлены принципы и стандарты эндоскопического мониторинга больных с предраковыми заболеваниями желудка.

The review summarizes literature data on the role of endoscopy in the diagnosis of Correa’s cascade, which is sequential development of adenocarcinoma through the stages of precancerous conditions’ progression from chronic non-atrophic gastritis to chronic atrophic gastritis with subsequent appearance of intestinal metaplasia and intraepithelial neoplasia. We paid special attention to criteria of early endoscopic diagnosis of gastric adenocarcinoma. We presented endoscopic monitoring principles and standards of patients with gastric precancerous conditions.

Каскад Корреакишечная метаплазияинтраэпителиальная неоплазияаденокарциномадиагностикаэндоскопия

Correa’s cascadeintestinal metaplasiaintraepithelial neoplasiaadenocarcinomadiagnosticsendoscopy

References1

Ghosn Y., Kamareddine M.H., Tawk A., Ayash N.B., Ayash H.B., Mokamer N., Yared R., Aoun M., Khoury S., Cortas G., Jabbour G., Bedran K., Farhat S. Analysis of Gastric and Duodenal Biopsy Results in Patients Presenting With Dyspepsia: A Cross-Sectional Study in a Middle Eastern Population. BMJ Open Gastroenterol. 2019 Sep 9. 6(1). e000330. doi: 10.1136/bmjgast-2019-000330.

Zamani M., Ebrahimtabar F., Zamani V., et al. Systematic review with meta-analysis: the world wide prevalence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2018. 47(7). 868- 876.

Plummer M., Franceschi S., Vignat J. et al.Global burden of gastric cancer attributable to Helicobacter pylori. Int. J. Cancer. 2014. 136. 487-490.

Koulis A., Buckle A., Boussioutas A. Premalignant lesions and gastric cancer: Current understanding. World J. Gastrointest. Oncol. 2019 Sep 15. 11(9). 665–678. Published online 2019 Sep 15. doi: 10.4251/wjgo.v11.i9.665.

Tsukamoto T., Nakagawa M., Kiriyama Y. et al. Prevention of gastric cancer: eradication of Helicobacter pylori and beyond. Int. J. Mol. Sci. 2017.18.1699.DOI -10.3390/ijms18081699.

Holleczek B., Schöttker B., Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population-based ESTHER cohort study. Int. J. Cancer. 2020 May 15. 146(10). 2773-2783. doi: 10.1002/ijc.32610. Epub 2019 Aug 29.

Gupta S., Tao L., Murphy J.D. et al. Race/ethnicity-, socioeconomic status-, and anatomic subsite-specific risks for gastric cancer. Gastroenterology. 2019. 156. 59-62.

Burkitt M.D., Duckworth C.A., Williams J.M., Pritchard D.M. Helicobacter pylori-induced gastric pathology: Insights from in vivo and ex vivo models. Dis Model Mech. 2017. 10. 89- 104.

Sugano K., Tack J. Kyoto global consensus reporton Helicobacter pylori gastritis. Gut. 2015. 64. 1353-1367.

Yagi K. Characteristic endoscopic and magnified endoscopic findings in the normal stomach without Helicobacter pylori infection. J. Gastroenterol. Gepatol. 2002 Jan. 17(1). 39-45.

Jeong C.Y., Kim N., Lee H.S., Yoon H., Shin C.M., Park Y.S., Kim J-W., Lee D.H. Risk Factors of Multiple Gastric Polyps according to the Histologic Classification: Prospective Observational Cohort Study. Korean J. Gastroenterol. 2019 Jul. 74(1). 17-29. English. Published online Jul 26, 2019. https://doi.org/10.4166/kjg.2019.74.1.17.

Niknam R., Manafi A., Maghbool M., Kouhpayeh A., Mahmoudi L. Is endoscopic nodular gastritis associated with premalignant lesions? Neth. J. Med. 2015. 73. 236-41.

Peng F.B., Graham D.Y., Tan M.C. Helicobacter pylori: An Update. IDSE. Infected disease special edition. APRIL 24, 2020.

Toyoshima O., Nishizawa T., Koike K. Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis. World J. Gastroenterol. Feb 7, 2020. 26(5). 466-477. Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.466.

Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018. 68(6). 394-424.

Niknam R., Manafi A., Fattahi M.R., Mahmoudi L. The association between gastric endoscopic findings and histologic premalignant lesions in the Iranian rural population. Medicine (Baltimore). 2015. 94. е 715.

Mahmoudi L., Sharifzadeh F., Mousavi S., Pourabbas B., Niknam R. Susceptibility testing of Helicobacter pylori: Comparison of E-test and disk diffusion for metronidazole and mutations in rdxA gene sequences of Helicobacter pylori strains. Trend sin Pharm. Sci. 2015. 1. 235-42.

Massironi S., Zilli A., Elvevi A., Invernizzi P. The Changing Face of Chronic Autoimmune Atrophic Gastritis: An Updated Comprehensive Perspective. Autoimmun. Rev. 2019 Mar. 18(3). 215-222. doi: 10.1016/j.autrev.2018.08.011. Epub 2019 Jan 11.

Parrish C.R. Chronic Atrophic Gastritis: Don’t Miss These Nutritional Deficiencies. Practical Gastroenterology. April 2020. p. 34-39.

Huang Y.K., Yu J.C., Kang W.M. et al. Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis. PLoS One. 2015. 10. e0142080.

Banks M., Graham D., Jansen M. et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019 Sep. 68(9). 1545-1575.

Gluckman C.R., Metz D.C. Gastric Neuroendocrine Tumors (Carcinoids). Current Gastroenterology Reports. 2019. 21. 13.

Wang H., Li L., Qin L.L. et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Data base of Systematic Reviews. 2018. Issue 3. Art. No.: CD004655.

Cavalcoli F., Zilli A., Conte D. et al. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review. World J. Gastroenterol. 2017 January 28. 23(4). 563-572.

Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology. February 2017. 112 (2). 212-239. doi: 10.1038/ajg.2016.563.

Yang Y.X., Brill J., Krishnan P. et al. American Gastroenterological Association Institute guideline on the role of upper gastrointestinal biopsy to evaluate dyspepsia in the adult patient in the absence of visible mucosal lesions. Gastroenterology. 2015. 149. 1082-1087.

Hassan T.M.M., Al-Najjar S.I., Al-Zahrani I.H., Alanazi F.I.B., Alotibi M.G. Helicobacter pylori chronic gastritis up dated Sydney gradinginrelation to endoscopic finding sand H. pylori Ig G antibody: diagnostic methods. J. Microsc. Ultrastruct. 2016 Oct-Dec. 4(4). 167-174. Published on line 2016 Mar 24. doi: 10.1016/j.jmau.2016.03.004.

Vance R.B.Jr., Kubiliun N., Dunbar K.B. How do we manage gastricintestinal metaplasia? A survey of clinical practice trends for gastrointestinal endoscopists in the United States. Dig. Dis. Sci. 2016. 61. 1870-1878.doi: 10.1007/s10620-016-4107-4. Epub 2016 Mar 17.

Zhang M., Liu S., Hu Y.,Bao H., Meng L., Wang X., Xu Y., Zhao J., Lu. B. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions. Scientific Reports. volume 9. Article number: 14909 (2019) Published: 17 October 2019.

Muto M., Yao K., Uedo N. et. al. Magnifying endoscopy simple diagnostical go rithm for early gastric cancer (MESDA-G). Digestive Endoscopy. 2016. 28. 379-393.

Buxbaum J.L., Hormozdi D., Dinis-Ribeiro M. et al. Narrow-band imaging versus white light vs mapping biopsy for gastric intestinal metaplasia: a prospective blinded trial. Gastrointest. Endosc. 2017. 86. 857-865.

Sáenz J.B., Vargas N., Mills J.C..Tropism for Spasmolytic Polypeptide-Expressing Metaplasia Allows Helicobacter Pylori to Expand Its Intragastric Niche. Gastroenterology. 2019 Jan. 156(1). 160-174. e7. doi: 10.1053/j.gastro.2018.09.050. Epub 2018 Oct 1.

Sáenz J.B., Vargas N., Mills J.C. Tropism for Spasmolytic Polypeptide-Expressing Metaplasia Allows Helicobacter Pylori to Expand Its Intragastric Niche. Gastroenterology. 2019 Jan. 156(1). 160-174. e7. doi: 10.1053/j.gastro.2018.09.050. Epub 2018 Oct 1.

VangeP., Bruland T., Bakke I. The cytoprotective protein clusterinis over expressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival. PLoS ONE. September 13. 2017. 12(9). 0184514. DOI: 10.1371/journal.pone.0184514.

Aasarod K.M., Waldum H.L., Stunes A.K., Sandvik A.K., Flatberg A., Mjоnes P., Syversen U., Bakke I., Fossmark R. Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H+/K+ATPase Beta Subunit Knockout Mice. Int. J. Mol. Sci. 2020. 21. 927. doi:10.3390/ijms21030927.

Quach D.T., Hiyama T. Assessment of Endoscopic Gastric Atrophy According to the Kimura- Takemoto Classification and Its Potential Application in Daily Practice. Clin. Endosc. 2019 Jul. 52(4). 321-327. Published on line 2019 Jul 22. doi: 10.5946/ce.2019.072.

Gawron A.J., Shah S.C., Altayar O. et al. AGA technical review on gastric intestinal metaplasia - natural history and clinical outcomes. Gastroenterology. 2020. 158. 705-731.

Pimentel-Nunes P., Libânio D., Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP) and Sociedade Port. Endoscopy. 2019. 51(4). 365-388.

Esposito G., Pimentel-Nunes P., Angeletti S., Castro R., Libânio D., Galli G., Lahner E., Di Giulio E., Annibale B., Dinis-Ribeiro M. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study. Endoscopy. 21 Dec 2018. 51(6). 515-521. DOI: 10.1055/a-0808-3186.

Esposito G., Pimentel-Nunes P., Angeletti S., Castro R., Libânio D., Galli G., Lahner E., Di Giulio E., Annibale B., Dinis-Ribeiro M. Endoscopic grading of gastric intestinal metaplasia(EGGIM): a multicenter validation study. Endoscopy. 21 Dec 2018. 51(6). 515-521. DOI: 10.1055/a-0808-3186.

Lee S.W. Diagnosis and management of gastric polyps. Korean J. Med. 2016. 90. 307-312.

Niknam R., Manafi A., Taghavi S.A. Relationship between Helicobacter Pylori infection and gastric dysplasia: Results from histology of gastric samples in the South of Iran. J. Med. Sci. 2019 Jun 2. 39. 177-81. Available from: http://www.jmedscindmc.com/text.asp?2019/39/4/177/261575.

Sung J.K. Diagnosis and management of gastric dysplasia. Korean J. Intern. Med. 2016. 31(2). 201-209. Published on line: February 26, 2016. DOI: https://doi.org/10.3904/kjim.2016.021.

Kwon M.J., Kang H.S., Kim H.T., Choo J.W., Lee B.H., Hong S.E., Park K.H., Jung D.M., Lim H., Soh J.S., Moon S.H., Kim J.H., Park H-R., Min S.K., Seo J.W., Choe J-Y. Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors. World J. Gastroenterol. Jan 28, 2019; 25(4): 469-484 Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.469.

Kwon M.J., Kang H.S., Kim H.T., Choo J.W., Lee B.H., Hong S.E., Park K.H., Jung D.M., Lim H., Soh J.S., Moon S.H., Kim J.H., Park H-R., Min S.K., Seo J., Choe J-Y.. Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors. World J. Gastroenterol. Jan 28, 2019. 25(4). 469-484. Published online Jan. 28, 2019. doi: 10.3748/wjg.v25.i4.469.

Gupta S., Li D., Serag H.B., Davitkov P., Altayar O., Sultan S., Falck-Ytter Y., Mustafa R.A. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology. February 2020. 158(3). 693-702. DOI: https://doi.org/10.1053/j.gastro.2019.12.003.

Banks M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019. 1. 1-31. doi:10.1136/gutjnl-2018-318126.

The authors declare that there are no conflicts of interest present.